PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
15-Apr-2021 TILT Biotherapeutics and MSD to collaborate on clinical trial of adenoviral cancer immunotherapeutic TILT-123 in combination with KEYTRUDA® (pembrolizumab) for ovarian cancer TILT Biotherapeutics
14-Apr-2021 Accelerating biopharmaceutical novelties: Körber joins the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Körber Business Area Pharma
13-Apr-2021 Co-innovation of Bioink and Powerful 2-Photon Bio-Printer Allows 3D-Printing with Living Cells for Bioapplications with Unprecedented Precision UpNano GmbH
13-Apr-2021 Oncurious NV Reports Encouraging Data from Phase 1 Dose Escalation Study of TB-403 in Paediatric Subjects with Relapsed or Refractory Medulloblastoma Presented at the American Association for Cancer Research 2021 Annual Meeting Oncurious NV
13-Apr-2021 Minoryx Phase 2/3 ‘ADVANCE’ study results to be presented at the 2021 American Neurological Association (AAN) Annual Meeting Minoryx Therapeutics
12-Apr-2021 Expansion of Lonza’s Automated Robotic Solution for Endotoxin Testing Automates Sustainable Recombinant Factor C Assay Lonza Group AG
12-Apr-2021 Tollys appoints Amina Zinaï, MD, as head of clinical development Andrew Lloyd Associates
12-Apr-2021 Calixar invests €1 Million in pipeline of highly druggable membrane protein targets and native antigens Andrew Lloyd Associates
12-Apr-2021 ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel Therapeutic Antibody to Treat Inflammatory Rheumatic Diseases ImmunOs Therapeutics
09-Apr-2021 Occupational Toxicology and Placing Worker Safety at the Forefront to be discussed at HPAPi Conference SMi Group
09-Apr-2021 Immutep achieves Fast Track Designation from US FDA for efti, a soluble LAB-3 protein, in first line recurrent/metastatic head and neck cancer Immutep
09-Apr-2021 Transgene presents initial Phase I data of TG6002, highlighting the potential of the intravenous administration of its oncolytic viruses Transgene
09-Apr-2021 ONCURIOUS Presenting Clinical and Preclinical Data at Upcoming American Association for Cancer Research (AACR) 2021 Annual Meeting ONCURIOUS NV.
09-Apr-2021 CancerFree Biotech Introduces New Cancer Drug Test That Only Requires Blood Samples CancerFree Biotech
08-Apr-2021 Exclusive Speaker Interview with Achim Kless, Pain Genetics Lead from Eli Lilly & Company ahead of Pain Therapeutics  SMi Group
08-Apr-2021 ONK Therapeutics Appoints Professor Philippe Moreau to its Scientific Advisory Board ONK Therapeutics
08-Apr-2021 Lynred selected to develop SWIR detector for European Land Surface Temperature Monitoring (LSTM) mission Andrew Lloyd Associates
08-Apr-2021 Domain Therapeutics presents most recent developments of its BRET technology portfolio at AACR and ASPET events Andrew Lloyd Associates
08-Apr-2021 Olympus Opens New Global HQ for Therapeutic Solutions Division and U.S. Medical Business ACN Newswire
07-Apr-2021 FDA Keynote Speakers at SMi's 4th Annual Pharmaceutical Microbiology East Coast Virtual Conference in 3 weeks SMi Group